NANO-MEDIA DEVELOPING IMMUNE TOLERANCE FOR ANTIGEN-SPECIFIC REMOVAL OF T-EFFECTOR CELLS

摘要

The methods of synthetic nano-carriers and related compositions are disclosed, including the administration of immunosuppressants and epitopes limited to the main class I histocompatibility complex and / or the main class II histocompatibility complex that can cause tolerant immune responses (eg, removal of antigen-specific T-effector cells).